Ultrasound Imaging
Gregory M. Lanza
Abstract
From the Division of Cardiology, Washington University School of Medicine, St Louis, MO. Received for publication March 17, 2020; and accepted for publication, after revision, March 17, 2020. Conflicts of interest and sources of funding: none declared. G.M.L. is a cofounder of Capella Imaging, Inc (nuclear imaging) and BGJ Pharma, LLC (nanomedicine). G.M.L. serves on the Scientific Advisory Board for KaloCyte, Inc. (artificial blood). G.M.L. enjoys cMRI research equipment and technical support from United Imaging in Healthcare America as part of an institutional collaboration with Washington University Medical School. All financial funding is derived from NIH grants: R01 CA216840, R01 HL122471, and U54 CA199092. Correspondence to: Gregory Lanza, MD, PhD, Division of Cardiology, Washington University School of Medicine, Cortex Bldg, Suite 101, 4320 Forest Park Ave, Saint Louis, MO 63108. E-mail: [email protected].